Pages that link to "Item:Q1794472"

The following pages link to Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472):

Displaying 34 items.

• Local controllability and optimal control for a model of combined anticancer therapy with control delays (Q335260) (← links)
• The nature of Hopf bifurcation for the Gompertz model with delays (Q409877) (← links)
• On an extension of a mathematical model for tumor anti-angiogenesis (Q425828) (← links)
• A topology Nash game for tumoral antiangiogenesis (Q438518) (← links)
• Computational modeling of tumor response to vascular-targeting therapies. I: Validation (Q541200) (← links)
• Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method (Q541886) (← links)
• Analysis of the Hopf bifurcation for the family of angiogenesis models (Q549750) (← links)
• Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics (Q662618) (← links)
• Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models (Q841345) (← links)
• Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays (Q902503) (← links)
• On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis (Q1019219) (← links)
• On optimal delivery of combination therapy for tumors (Q1042733) (← links)
• An optimal control approach for the treatment of solid tumors with angiogenesis inhibitors (Q1649031) (← links)
• Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy (Q1653067) (← links)
• On dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapies (Q1709157) (← links)
• Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer (Q1712868) (← links)
• Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy (Q1942445) (← links)
• Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis (Q1942451) (← links)
• New approach to modeling of antiangiogenic treatment on the basis of Hahnfeldt et al. model (Q1942472) (← links)
• On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
• On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
• Stability analysis of the family of tumour angiogenesis models with distributed time delays (Q2199481) (← links)
• Numerical solution for a problem arising in angiogenic signalling (Q2335309) (← links)
• On assessing quality of therapy in non-linear distributed mathematical models for brain tumor growth dynamics (Q2452805) (← links)
• Tumour growth control: analysis of alternative approaches (Q2693199) (← links)
• Tumor Development Under Combination Treatments with Anti-angiogenic Therapies (Q2820388) (← links)
• Optimal protocols for the anti-VEGF tumor treatment (Q2874982) (← links)
• Optimal solutions for a model of tumor anti-angiogenesis with a penalty on the cost of treatment (Q3184355) (← links)
• Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment (Q3467045) (← links)
• AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem (Q3506537) (← links)
• Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment (Q3574841) (← links)
• Existence of Solutions and Local Null Controllability for a Model of Tissue Invasion by Solid Tumors (Q4570978) (← links)
• Delay Differential Equations in Bio-Populations (Q4628547) (← links)
• Optimal Control Problem for Cancer Invasion Reaction–Diffusion System (Q4632342) (← links)